The BSE, founded in 1875, is Asia's oldest stock exchange — it started under a banyan tree on Dalal Street, where the bronze bull stands today.
The BSE, founded in 1875, is Asia's oldest stock exchange — it started under a banyan tree on Dalal Street, where the bronze bull stands today.
The BSE, founded in 1875, is Asia's oldest stock exchange — it started under a banyan tree on Dalal Street, where the bronze bull stands today.
Nureca Limited is a specialist in home healthcare and wellness products. Its products serve individuals, caregivers and medical practitioners across the globe. It offers a range of products specialized in home-based, non-invasive digital diagnosis and prevention of lifestyle…
Weekly engine runs — movement reflects the numbers, not analyst opinion.
A middling business, reasonably priced — but flagged on governance.
NURECA is scored on the pharma / healthcare framework. It keeps a thin 1.3% of every rupee of sales as net profit. Those profits are backed by real cash — operating cash flow runs 1.59× reported profit. It throws off free cash worth 6.1% of its market value — a strong free-cash yield.
Net worth has actually shrunk (-3%/yr) — value is not being built. Return on equity is a weak 2.5%. In the latest quarter profit grew 32% versus the prior quarter.
At 143× earnings, the stock sits at the 23rd percentile of its own 1.6-year range — the cheap end of where it has historically traded. Today's price already implies ~24%/yr earnings growth sustained for a decade — a demanding bar. The forensic screen raises a red flag: 163% of pre-tax profit is other income, not operations.
A plain-English restatement of the figures on this page — rules-based, for education and research context, not investment advice or a recommendation.
| Ratio | Company | Sector | Read |
|---|---|---|---|
| P/E | 60.92 | 36.85 | worse |
| P/B | 1.54 | 2.77 | better |
| EV/EBITDA | 18.03 | 16.77 | worse |
| ROE | 2.53 | 8.8 | worse |
| ROCE | 5.21 | 11.83 | worse |
| ROA | 2.06 | — | — |
| Quick Ratio | 4.88 | 3.03 | better |
| Peer | P/E | P/B | ROE |
|---|---|---|---|
| Zomato | 711.8 | 11.2 | 1.6% |
| Paytm | 134.9 | 6.9 | 5.2% |
| Nykaa | 308.9 | 61.0 | 19.5% |
9% CAGR — growing but slowly. Growth is accelerating — latest year outpaced the prior year's rate.
2 of the 4 years shown had a loss — profitability is inconsistent. The latest year saw a +145% swing — check if it's a one-off or structural.
Operating margin has expanded from -9% to 3% — the business is keeping more of each rupee earned. The gap between operating and net margin is widening — interest or tax costs are rising.
ROE at 1% — modest; the capital isn't working hard. Capital efficiency improving — ROE up 5pp across the window.
EPS has grown every year — each share earns more than the last, consistently. EPS outpaced profit growth — possible buybacks are concentrating earnings into fewer shares. 148% EPS CAGR — this is the rate at which each share's claim on earnings is compounding.
2 of 4 years had negative operating cash flow — profitability on paper may not translate to cash. Cash conversion at 1.6× PAT — earnings are well-backed by cash; strong accrual quality. Financing outflows in consecutive years — balance-sheet discipline through debt repayment or dividends.
When operating cash keeps pace with reported profit, earnings are cash-backed; a persistent shortfall is a quality flag.
Revenue rose 42% sequentially — momentum is building. Wide quarterly swings (39% spread) — likely seasonality, lumpy orders, or project-based revenue. Run-rate stepping up — recent quarters average 30% above earlier ones.
1 of 4 quarters loss-making — quarterly profitability is uneven. Profit jumped 32% QoQ — check if this is operating leverage or a one-off item. Quarterly margins are compressing (9% → 7%) — more revenue isn't translating to proportionally more profit.
How today's P/E compares to the stock's own historical range. Dashed line = the 1.6y median.
Promoters hold 70.7% — heavily owner-operated with strong skin in the game. Promoters added 2.6pp over 4 quarters — creeping acquisition signals conviction.
Produced by a rules-based engine over licensed exchange fundamentals — every sentence above is derived from the numbers shown, no analyst or AI opinion involved. Education and research context, not investment advice. We are not SEBI-registered as an Investment Adviser or Research Analyst.